About Dr Reddy’s
Established in 1984, Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and News Chemical Entities (NCEs).
Headquartered in India, Dr Reddy’s has a presence in more than 100 countries, with wholly-owned subsidiaries in the US, UK, Russia, Germany and Brazil; joint ventures in China, South Africa and Australia; representative offices in 16 countries; and third-party distribution set ups in 21 countries. Dr. Reddy’s is also the first pharmaceutical company in Asia outside of Japan to be listed on the NYSE.
Dr. Reddy’s Laboratories was founded by Dr Anji Reddy, an entrepreneur-scientist, in 1984. The DNA of the company is drawn from its founder and his vision to establish India’s first discovery-led global pharmaceutical company.
With over 15,000 employees working across the globe the company continues its relentless march forward to make a difference to people’s lives worldwide. Dr Reddy’s strong portfolio of businesses, geographies and products provides us with the strategic benefits of vertical integration that allow the company to excel in an increasingly competitive global market.